Search Page

1

Cite

Share

Outcome measures in systemic sclerosis: an update on instruments and current research.

Khanna D, Merkel PA. Khanna D, et al. Curr Rheumatol Rep. 2007 May;9(2):151-7. doi: 10.1007/s11926-007-0010-5. Curr Rheumatol Rep. 2007. PMID: 17502046 Review.

Cite

Share

2

Cite

Share

Systemic sclerosis - continuing progress in developing clinical measures of response.

Furst D, Khanna D, Matucci-Cerinic M, Clements P, Steen V, Pope J, Merkel P, Foeldvari I, Seibold J, Pittrow D, Polisson R, Strand V. Furst D, et al. J Rheumatol. 2007 May;34(5):1194-200. J Rheumatol. 2007. PMID: 17477486 Review.

Cite

Share

3

Cite

Share

Infliximab for maintenance of glucocorticosteroid-induced remission of giant cell arteritis: a randomized trial.

Hoffman GS, Cid MC, Rendt-Zagar KE, Merkel PA, Weyand CM, Stone JH, Salvarani C, Xu W, Visvanathan S, Rahman MU; Infliximab-GCA Study Group. Hoffman GS, et al. Ann Intern Med. 2007 May 1;146(9):621-30. doi: 10.7326/0003-4819-146-9-200705010-00004. Ann Intern Med. 2007. PMID: 17470830 Clinical Trial.

Cite

Share

4

Cite

Share

Antiproteinase 3 antineutrophil cytoplasmic antibodies and disease activity in Wegener granulomatosis.

Finkielman JD, Merkel PA, Schroeder D, Hoffman GS, Spiera R, St Clair EW, Davis JC Jr, McCune WJ, Lears AK, Ytterberg SR, Hummel AM, Viss MA, Peikert T, Stone JH, Specks U; WGET Research Group. Finkielman JD, et al. Ann Intern Med. 2007 Nov 6;147(9):611-9. doi: 10.7326/0003-4819-147-9-200711060-00005. Ann Intern Med. 2007. PMID: 17975183 Clinical Trial.

Cite

Share

5

Cite

Share

Hearing loss in Wegener's granulomatosis.

Bakthavachalam S, Driver MS, Cox C, Spiegel JH, Grundfast KM, Merkel PA. Bakthavachalam S, et al. Otol Neurotol. 2004 Sep;25(5):833-7. doi: 10.1097/00129492-200409000-00030. Otol Neurotol. 2004. PMID: 15354019

Cite

Share

6

Cite

Share

Relationship between markers of platelet activation and inflammation with disease activity in Wegener's granulomatosis.

Tomasson G, Lavalley M, Tanriverdi K, Finkielman JD, Davis JC Jr, Hoffman GS, McCune WJ, St Clair EW, Specks U, Spiera R, Stone JH, Freedman JE, Merkel PA; Wegener's Granulomatosis Etanercept Trial (WGET) Research Group. Tomasson G, et al. J Rheumatol. 2011 Jun;38(6):1048-54. doi: 10.3899/jrheum.100735. Epub 2011 Mar 16. J Rheumatol. 2011. PMID: 21411717 Free PMC article.

Cite

Share

7

Cite

Share

ANCA are detectable in nearly all patients with active severe Wegener's granulomatosis.

Finkielman JD, Lee AS, Hummel AM, Viss MA, Jacob GL, Homburger HA, Peikert T, Hoffman GS, Merkel PA, Spiera R, St Clair EW, Davis JC Jr, McCune WJ, Tibbs AK, Ytterberg SR, Stone JH, Specks U; WGET Research Group. Finkielman JD, et al. Am J Med. 2007 Jul;120(7):643.e9-14. doi: 10.1016/j.amjmed.2006.08.016. Am J Med. 2007. PMID: 17602941

Cite

Share

8

Cite

Share

Part 1: The need for novel treatment regimens for ANCA-associated vasculitis.

Merkel PA. Merkel PA. Clin Exp Rheumatol. 2007 Jan-Feb;25(1 Suppl 44):S72-3. Clin Exp Rheumatol. 2007. PMID: 17428375 Review. No abstract available.

Cite

Share

9

Cite

Share

Development of a provisional core set of response measures for clinical trials of systemic sclerosis.

Khanna D, Lovell DJ, Giannini E, Clements PJ, Merkel PA, Seibold JR, Matucci-Cerinic M, Denton CP, Mayes MD, Steen VD, Varga J, Furst DE; Scleroderma Clinical Trials Consortium co-authors. Khanna D, et al. Ann Rheum Dis. 2008 May;67(5):703-9. doi: 10.1136/ard.2007.078923. Epub 2007 Sep 24. Ann Rheum Dis. 2008. PMID: 17893248 Free PMC article.

Cite

Share

10

Cite

Share

Antiendothelial cell antibodies in patients with Wegener's granulomatosis: prevalence and correlation with disease activity and manifestations.

Sebastian JK, Mahr AD, Ahmed SS, Stone JH, Romay-Penabad Z, Davis JC, Hoffman GS, McCune WJ, St Clair EW, Specks U, Spiera R, Pierangeli S, Merkel PA. Sebastian JK, et al. J Rheumatol. 2007 May;34(5):1027-31. Epub 2007 Apr 15. J Rheumatol. 2007. PMID: 17444585

Cite

Share